Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210


Biomarkers of Cancer-Associated Thromboembolism.

Mahajan A, Wun T.

Cancer Treat Res. 2019;179:69-85. doi: 10.1007/978-3-030-20315-3_5.


High incidence of venous thromboembolism recurrence in patients with sickle cell disease.

Brunson A, Keegan T, Mahajan A, White R, Wun T.

Am J Hematol. 2019 Aug;94(8):862-870. doi: 10.1002/ajh.25508. Epub 2019 Jun 12.


The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update.

Mahajan A, Brunson A, White R, Wun T.

Semin Thromb Hemost. 2019 Jun;45(4):321-325. doi: 10.1055/s-0039-1688494. Epub 2019 Apr 30.


Impact of health insurance on stage at cancer diagnosis among adolescent and young adults.

Keegan THM, Parsons HM, Chen Y, Maguire FB, Morris CR, Parikh-Patel A, Kizer KW, Wun T.

J Natl Cancer Inst. 2019 Apr 1. pii: djz039. doi: 10.1093/jnci/djz039. [Epub ahead of print]


Decreased Early Mortality in Young Adult Patients With Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California.

Alvarez EM, Malogolowkin M, Li Q, Brunson A, Pollock BH, Muffly L, Wun T, Keegan THM.

J Oncol Pract. 2019 Apr;15(4):e316-e327. doi: 10.1200/JOP.18.00264. Epub 2019 Mar 8.


Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators.

N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630.


Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer.

Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, Flaumenhaft R; CATIQ Investigators11.

JCI Insight. 2019 Feb 21;4(4). pii: 125851. doi: 10.1172/jci.insight.125851. eCollection 2019 Feb 21.


Unplanned Hospitalization Among Individuals With Cancer in the Year After Diagnosis.

Whitney RL, Bell JF, Tancredi DJ, Romano PS, Bold RJ, Wun T, Joseph JG.

J Oncol Pract. 2019 Jan;15(1):e20-e29. doi: 10.1200/JOP.18.00254. Epub 2018 Dec 5.


Cancer specific survival in patients with sickle cell disease.

Brunson A, Keegan THM, Mahajan A, Paulukonis S, Wun T.

Br J Haematol. 2019 Apr;185(1):128-132. doi: 10.1111/bjh.15687. Epub 2018 Nov 22.


Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States.

Parsons HM, Penn DC, Li Q, Cress RD, Pollock BH, Malogolowkin MH, Wun T, Keegan THM.

Pediatr Blood Cancer. 2019 Jan;66(1):e27426. doi: 10.1002/pbc.27426. Epub 2018 Sep 6.


Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.

Yap SA, Brunson A, Pugashetti N, M P H RDC, Keegan THM, deVere White R, Wun T.

Urol Oncol. 2018 Nov;36(11):498.e1-498.e7. doi: 10.1016/j.urolonc.2018.08.004. Epub 2018 Sep 17.


The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease.

DiMartino LD, Baumann AA, Hsu LL, Kanter J, Gordeuk VR, Glassberg J, Treadwell MJ, Melvin CL, Telfair J, Klesges LM, King A, Wun T, Shah N, Gibson RW, Hankins JS; Sickle Cell Disease Implementation Consortium.

Am J Hematol. 2018 Dec;93(12):E391-E395. doi: 10.1002/ajh.25282. Epub 2018 Oct 17. No abstract available.


Complications and early mortality in patients with acute promyelocytic leukemia treated in California.

Ho G, Li Q, Brunson A, Jonas BA, Wun T, Keegan THM.

Am J Hematol. 2018 Nov;93(11):E370-E372. doi: 10.1002/ajh.25252. Epub 2018 Sep 26. No abstract available.


Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.

Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T.

J Natl Cancer Inst. 2019 Jan 1;111(1):78-85. doi: 10.1093/jnci/djy073.


How I diagnose and treat venous thromboembolism in sickle cell disease.

Shet AS, Wun T.

Blood. 2018 Oct 25;132(17):1761-1769. doi: 10.1182/blood-2018-03-822593. Epub 2018 May 15. Review.


Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.

O'Keefe D, Aung SM, Pasricha N, Wun T, Linn SK, Lin N, Aitken C, Hughes C, Dietze P.

Int J Drug Policy. 2018 Aug;58:22-30. doi: 10.1016/j.drugpo.2018.04.010. Epub 2018 May 11.


Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.

Keegan THM, Li Q, Steele A, Alvarez EM, Brunson A, Flowers CR, Glaser SL, Wun T.

Cancer Causes Control. 2018 Jun;29(6):551-561. doi: 10.1007/s10552-018-1025-0. Epub 2018 Apr 13.


Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.

Ho PY, Duan Z, Batra N, Jilek JL, Tu MJ, Qiu JX, Hu Z, Wun T, Lara PN, DeVere White RW, Chen HW, Yu AM.

J Pharmacol Exp Ther. 2018 Jun;365(3):494-506. doi: 10.1124/jpet.118.247775. Epub 2018 Mar 30.


Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.

Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas BA, Keegan THM.

Cancer. 2018 May 1;124(9):1938-1945. doi: 10.1002/cncr.31296. Epub 2018 Feb 16.


Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.

Keegan THM, Kushi LH, Li Q, Brunson A, Chawla X, Chew HK, Malogolowkin M, Wun T.

J Cancer Surviv. 2018 Jun;12(3):388-397. doi: 10.1007/s11764-018-0678-8. Epub 2018 Feb 9.


Care at specialized cancer centers among young adults with acute lymphoblastic leukemia in California.

Alvarez E, Muffly L, Li Q, Brunson A, Wun T, Chamberlain L, Keegan T.

Leuk Lymphoma. 2018 Oct;59(10):2482-2484. doi: 10.1080/10428194.2018.1427856. Epub 2018 Feb 9. No abstract available.


Passivating Injured Endothelium with Kinexins in Thrombolytic Therapy.

Ma YH, Huang CW, Wen CJ, Lu YC, Wey SP, Wun TC.

Thromb Haemost. 2018 Jan;118(1):90-102. doi: 10.1160/TH17-05-0330. Epub 2018 Jan 5.


Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Adesina O, Brunson A, Keegan THM, Wun T.

Blood Adv. 2017 Jul 11;1(16):1287-1295. doi: 10.1182/bloodadvances.2017005256. eCollection 2017 Jul 11.


Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.

Khorana AA, Vadhan-Raj S, Kuderer NM, Wun T, Liebman H, Soff G, Belani C, O'Reilly EM, McBane R, Eikelboom J, Damaraju CV, Beyers K, Dietrich F, Kakkar AK, Riess H, Peixoto RD, Lyman GH.

Thromb Haemost. 2017 Nov 1;117(11):2135-2145. doi: 10.1160/TH17-03-0171. Epub 2017 Sep 21.


Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance.

Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA.

Blood Cancer J. 2017 Sep 8;7(9):e605. doi: 10.1038/bcj.2017.81.


Active Reading of Visualizations.

Walny J, Huron S, Perin C, Wun T, Pusch R, Carpendale S.

IEEE Trans Vis Comput Graph. 2018 Jan;24(1):770-780. doi: 10.1109/TVCG.2017.2745958. Epub 2017 Aug 29.


Assessing the Graphical Perception of Time and Speed on 2D+Time Trajectories.

Perin C, Wun T, Pusch R, Carpendale S.

IEEE Trans Vis Comput Graph. 2018 Jan;24(1):698-708. doi: 10.1109/TVCG.2017.2743918. Epub 2017 Aug 29.


Increased risk of leukemia among sickle cell disease patients in California.

Brunson A, Keegan THM, Bang H, Mahajan A, Paulukonis S, Wun T.

Blood. 2017 Sep 28;130(13):1597-1599. doi: 10.1182/blood-2017-05-783233. Epub 2017 Aug 22. No abstract available.


Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow.

Morikis VA, Chase S, Wun T, Chaikof EL, Magnani JL, Simon SI.

Blood. 2017 Nov 9;130(19):2101-2110. doi: 10.1182/blood-2017-05-783027. Epub 2017 Aug 15.


Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.

Yeh YH, Chang SH, Chen SY, Wen CJ, Wei FC, Tang R, Achilefu S, Wun TC, Chen WJ.

Int J Cardiol. 2017 Aug 1;240:339-346. doi: 10.1016/j.ijcard.2017.03.150. Epub 2017 Apr 6.


Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.

Ho G, Jonas BA, Li Q, Brunson A, Wun T, Keegan THM.

Br J Haematol. 2017 Jun;177(5):791-799. doi: 10.1111/bjh.14631. Epub 2017 Apr 17.


Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models.

Jian C, Tu MJ, Ho PY, Duan Z, Zhang Q, Qiu JX, DeVere White RW, Wun T, Lara PN, Lam KS, Yu AX, Yu AM.

Oncotarget. 2017 May 9;8(19):30742-30755. doi: 10.18632/oncotarget.16372.


Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.

Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T.

Br J Haematol. 2017 Jul;178(2):319-326. doi: 10.1111/bjh.14655. Epub 2017 Apr 3.


Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study.

Brunson A, Ho G, White R, Wun T.

Thromb Res. 2017 May;153:57-64. doi: 10.1016/j.thromres.2017.03.012. Epub 2017 Mar 16.


Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.

Shyu VB, Hsu CE, Wen CJ, Wun TC, Tang R, Achilefu S, Wei FC, Cheng HY.

Ann Plast Surg. 2017 Mar;78(3 Suppl 2):S129-S134. doi: 10.1097/SAP.0000000000001018.


Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.

Khorana AA, Francis CW, Kuderer NM, Carrier M, Ortel TL, Wun T, Rubens D, Hobbs S, Iyer R, Peterson D, Baran A, Kaproth-Joslin K, Lyman GH.

Thromb Res. 2017 Mar;151:89-95. doi: 10.1016/j.thromres.2017.01.009. Epub 2017 Jan 26.


Sickle cell disease: an inherited thrombophilia.

Wun T, Brunson A.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):640-647. Review.


Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy.

Chen M, Qiu H, Lin X, Nam D, Ogbu-Nwobodo L, Archibald H, Joslin A, Wun T, Sawamura T, Green R.

Blood Cells Mol Dis. 2016 Sep;60:44-8. doi: 10.1016/j.bcmd.2016.06.005. Epub 2016 Jun 25.


Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes.

Brunson A, Ho G, White R, Wun T.

Thromb Res. 2016 Apr;140 Suppl 1:S132-41. doi: 10.1016/S0049-3848(16)30112-8.


Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study.

White RH, Brunson A, Romano PS, Li Z, Wun T.

Circulation. 2016 May 24;133(21):2018-29. doi: 10.1161/CIRCULATIONAHA.115.020338. Epub 2016 Apr 5.


Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.

Terry CM, Zhuplatov I, He Y, Wun TC, Kim SE, Cheung AK.

PLoS One. 2015 Sep 11;10(9):e0137381. doi: 10.1371/journal.pone.0137381. eCollection 2015.


Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.

Wang WP, Ho PY, Chen QX, Addepalli B, Limbach PA, Li MM, Wu WJ, Jilek JL, Qiu JX, Zhang HJ, Li T, Wun T, White RD, Lam KS, Yu AM.

J Pharmacol Exp Ther. 2015 Aug;354(2):131-41. doi: 10.1124/jpet.115.225631. Epub 2015 May 28.


Vena cava filter use in cancer patients with acute venous thromboembolism in California.

Ho G, Brunson A, White R, Wun T.

Thromb Res. 2015 May;135(5):809-15. doi: 10.1016/j.thromres.2015.02.002. Epub 2015 Feb 7.


Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.

Telen MJ, Wun T, McCavit TL, De Castro LM, Krishnamurti L, Lanzkron S, Hsu LL, Smith WR, Rhee S, Magnani JL, Thackray H.

Blood. 2015 Apr 23;125(17):2656-64. doi: 10.1182/blood-2014-06-583351. Epub 2015 Mar 2.


Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.

Wun T, Styles L, DeCastro L, Telen MJ, Kuypers F, Cheung A, Kramer W, Flanner H, Rhee S, Magnani JL, Thackray H.

PLoS One. 2014 Jul 2;9(7):e101301. doi: 10.1371/journal.pone.0101301. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e111690.


Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.

Lara MS, Brunson A, Wun T, Tomlinson B, Qi L, Cress R, Gandara DR, Kelly K.

Lung Cancer. 2014 Aug;85(2):264-9. doi: 10.1016/j.lungcan.2014.04.007. Epub 2014 May 6.


Lymphoma and venous thromboembolism: influence on mortality.

Mahajan A, Wun T, Chew H, White RH.

Thromb Res. 2014 May;133 Suppl 2:S23-8. doi: 10.1016/S0049-3848(14)50004-7.


Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.

Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA.

J Clin Oncol. 2014 Jun 10;32(17):1792-6. doi: 10.1200/JCO.2013.53.5336. Epub 2014 May 5.


Adverse impact of venous thromboembolism on patients with cancer.

Arora M, Wun T.

Semin Thromb Hemost. 2014 Apr;40(3):313-8. doi: 10.1055/s-0034-1370769. Epub 2014 Mar 5. Review.


Supplemental Content

Support Center